Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Norofen Wormer 220 mg Granules is a Health Canada–registered veterinary drug (DIN 02240614) held by Norbrook Laboratories Ltd., containing Fenbendazole. Health Canada lists its status as Cancelled Pre Market (status date 28 Nov 2018). Nexara Health has matched 13 registrations of Fenbendazole across 3 other regulated markets.

Health Canada registration

DIN02240614
Brand nameNorofen Wormer
Active ingredientFenbendazole
Strength220 mg
Dosage formGranules
RouteOral
CompanyNorbrook Laboratories Ltd.
StatusCancelled Pre Market — 28 Nov 2018
ClassVeterinary
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Fenbendazole registered in other markets

13 registrations of the same molecule in 3 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
European Union (EMA)CunitraxxAvimedical B.V.Application withdrawnEMA centrally authorised
European Union (EMA)Panacur AquaSol—AuthorisedEMA centrally authorised
MalaysiaFenbenzole 10% w/v Oral SuspensionVision Biotech Sdn BhdVeterinaryPRODUCT APPROVEDNPRA
MalaysiaFenzole (Fenbendazole Oral Suspension 10% w/v)KM Vet Pharm Sdn. Bhd.VeterinaryPRODUCT APPROVEDNPRA
MalaysiaGallifen 200mg/ml suspension for use in drinking water for chickenPahang Pharmacy Sdn. Bhd.VeterinaryPRODUCT APPROVEDNPRA
MalaysiaPAN-CURE Dewormer 4 % Premix PowderWeissen Company (m) Sdn. Bhd.VeterinaryPRODUCT APPROVEDNPRA
MalaysiaPVP- Fenbendazole 10% w/v SuspensionPelangi Vet Pharma Sdn. Bhd.VeterinaryPRODUCT APPROVEDNPRA
United StatesFenbendazoleAlivira Animal Health LimitedPowderFDA NDC
United StatesFenbendazoleMedisca Inc.PowderFDA NDC
United StatesFenbendazoleShaanxi Hanjiang Pharmaceutical Group Co., Ltd.PowderFDA NDC
United StatesFenbendazoleKalchem International incPowderFDA NDC
United StatesFenbendazole 222 MGB & L Healthcare Products INCCapsulelistedFDA NDC
United StatesPREPAKU FENBENDAZOLE Canine DewormerShenzhen Zhenshangzekai Technology Co., Ltd.GranulelistedFDA NDC

See every manufacturer of Fenbendazole worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Norofen Wormer (DIN 02240614) marketed in Canada?

No. Health Canada lists DIN 02240614 as Cancelled Pre Market as of 28 Nov 2018.

Who holds the Canadian licence for this product?

Norbrook Laboratories Ltd. is the company of record in the Health Canada Drug Product Database.

Is Fenbendazole registered outside Canada?

Yes — Nexara Health has matched 13 registrations in 3 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02240614, status date 2018-11-28; national medicine registries: EMA centrally authorised, FDA NDC, NPRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02240614, status date 2018-11-28; national medicine registries: EMA centrally authorised, FDA NDC, NPRA.

Health Canada Drug Product Database (DPD), DIN 02240614, status date 2018-11-28; national medicine registries: EMA centrally authorised, FDA NDC, NPRA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.